Medivir names Dr. Tom Morris as interim Chief Medical Officer

Medivir names Dr. Tom Morris as interim Chief Medical Officer

Medivir has appointed Dr. Tom Morris as interim Chief Medical Officer effective October 5, 2020. Dr. Morris will report to CEO Yilmaz Mahshid and join the Medivir Executive Team.

Tom Morris has more than 20 years of experience within drug development, mostly in oncology. Previously employed at Medeval Ltd and more recently at AstraZeneca. He has overseen the clinical development of several global drug programs, interacting with regulatory agencies, external clinical experts and academic groups worldwide.

Dr. Morris holds a BSc in Physiology from the University of Wales, medical degrees from the University of Wales College of Medicine and Master of Laws degree from Cardiff Law School. Currently a fellow and Board member of The Faculty of Pharmaceutical Medicine, a former chair of its Ethical Issues committee and a member of its Professional Standards Committee.


Notice: Trying to access array offset on value of type bool in /home/pagejupy/public_html/wp-content/themes/blogwp-pro/inc/functions/share-buttons.php on line 36
Share: